IL10 positively regulates extracellular inflammatory mediators

Stable Identifier
Reaction [omitted]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
IL10 enhances activated monocyte expression of the natural antagonists interleukin-1 receptor antagonist (IL1RN), TNFRSF1A (soluble p55 TNFR) and TNFRSF1B (p75 TNFR) (Cassatella et al 1994, Hart et al. 1996, Joyce & Steer 1996, Linderholm et al. 1996, Dickensheets et al. 1997).

IL10 enhances production of tissue inhibitor of metalloproteinases (TIMP1) and hyaluronectin, which bind and inhibit the angiogenic- and migration-promoting activities of hyaluronic acid (Mertz et al. 1994, Lacraz et al. 1995, Stearns et al. 1999, Girard et al. 1999).
Literature References
PubMed ID Title Journal Year
8537680 Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome

Settergren, B, Ahlm, C, Tärnvik, A, Waage, A, Linderholm, M

J. Infect. Dis. 1996
8871669 Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10

Bonder, CS, Finlay-Jones, JJ, Watson, CJ, Hart, PH, Hunt, EK

J. Immunol. 1996
7593617 IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes

Lacraz, S, Welgus, HG, Chicheportiche, R, Dayer, JM, Nicod, LP

J. Clin. Invest. 1995
8742066 IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes

Steer, JH, Joyce, DA

Cytokine 1996
9354687 Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes

Freeman, SL, Smith, MF, Donnelly, RP, Dickensheets, HL

Blood 1997
8163946 Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation

Gasperini, S, Bonora, S, Calzetti, F, Cassatella, MA, Meda, L

J. Exp. Med. 1994
9918218 Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion

Stearns, ME, Wang, M, Rhim, J

Clin. Cancer Res. 1999
8063757 Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production

DeWitt, DL, Wahl, LM, Stetler-Stevenson, WG, Mertz, PM

J. Biol. Chem. 1994
1460289 IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10

Figdor, CG, te Velde, AA, Huijbens, RJ, de Vries, JE, de Waal Malefijt, R

J. Immunol. 1992
This event is regulated
Cite Us!